Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Casale

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Opinion on Therapeutic Patents|February 6, 2013
PARP inhibitors in cancer therapy: an updateGianluca Papeo, Elena Casale, Alessia Montagnoli, et al.
Journal of Medicinal Chemistry|December 17, 2009
Through the "gatekeeper door": exploiting the active kinase conformationFabio Zuccotto, Elena Ardini, Elena Casale, et al.
Journal of Molecular Graphics & Modelling|November 2, 2005
Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitorsAnna Vulpetti, Elena Casale, Fulvia Roletto, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Structure-based optimization of potent PDK1 inhibitorsMauro Angiolini, Patrizia Banfi, Elena Casale, et al.
Biochemistry|August 7, 2013
Structural insight into maternal embryonic leucine zipper kinase (MELK) conformation and inhibition toward structure-based drug designGiulia Canevari, Stefania Re Depaolini, Ulisse Cucchi, et al.
Cancer Research|September 7, 2007
Crystal structure of the T315I Abl mutant in complex with the aurora kinases inhibitor PHA-739358Michele Modugno, Elena Casale, Chiara Soncini, et al.
Bioorganic & Medicinal Chemistry|July 2, 2014
Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitorsElena Casale, Nadia Amboldi, Maria Gabriella Brasca, et al.
Chirality|August 12, 2022
Stereoselective synthesis of 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as PIM kinase inhibitors inspired from marine alkaloidsFrancesco Casuscelli, Elena Ardini, Nilla Avanzi, et al.
Journal of Medicinal Chemistry|February 10, 2010
Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitorsGabriella Traquandi, Marina Ciomei, Dario Ballinari, et al.
Chemmedchem|November 29, 2014
Optimization of diarylthiazole B-raf inhibitors: identification of a compound endowed with high oral antitumor activity, mitigated hERG inhibition, and low paradoxical effectMaurizio Pulici, Gabriella Traquandi, Chiara Marchionni, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Patents|February 6, 2013
PARP inhibitors in cancer therapy: an updateGianluca Papeo, Elena Casale, Alessia Montagnoli, et al.
Journal of Medicinal Chemistry|December 17, 2009
Through the "gatekeeper door": exploiting the active kinase conformationFabio Zuccotto, Elena Ardini, Elena Casale, et al.
Journal of Molecular Graphics & Modelling|November 2, 2005
Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitorsAnna Vulpetti, Elena Casale, Fulvia Roletto, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Structure-based optimization of potent PDK1 inhibitorsMauro Angiolini, Patrizia Banfi, Elena Casale, et al.
Biochemistry|August 7, 2013
Structural insight into maternal embryonic leucine zipper kinase (MELK) conformation and inhibition toward structure-based drug designGiulia Canevari, Stefania Re Depaolini, Ulisse Cucchi, et al.
Cancer Research|September 7, 2007
Crystal structure of the T315I Abl mutant in complex with the aurora kinases inhibitor PHA-739358Michele Modugno, Elena Casale, Chiara Soncini, et al.
Bioorganic & Medicinal Chemistry|July 2, 2014
Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitorsElena Casale, Nadia Amboldi, Maria Gabriella Brasca, et al.
Chirality|August 12, 2022
Stereoselective synthesis of 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as PIM kinase inhibitors inspired from marine alkaloidsFrancesco Casuscelli, Elena Ardini, Nilla Avanzi, et al.
Journal of Medicinal Chemistry|February 10, 2010
Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitorsGabriella Traquandi, Marina Ciomei, Dario Ballinari, et al.
Chemmedchem|November 29, 2014
Optimization of diarylthiazole B-raf inhibitors: identification of a compound endowed with high oral antitumor activity, mitigated hERG inhibition, and low paradoxical effectMaurizio Pulici, Gabriella Traquandi, Chiara Marchionni, et al.
Pageof 3